Spine News and Research

RSS
Medtronic fourth quarter revenue increases 4% to $4.297 billion

Medtronic fourth quarter revenue increases 4% to $4.297 billion

Regenerative medicine researchers explore innovative ways to treat childhood conditions

Regenerative medicine researchers explore innovative ways to treat childhood conditions

Specialized high volume centers linked with lower rates of death and disability from aSAH

Specialized high volume centers linked with lower rates of death and disability from aSAH

Tiny filter could fight against tuberculosis

Tiny filter could fight against tuberculosis

Simple pull-to-sit task could predict risk of ASD in infants

Simple pull-to-sit task could predict risk of ASD in infants

Patients with morbid obesity more likely to develop complications after spinal fusion surgery

Patients with morbid obesity more likely to develop complications after spinal fusion surgery

Age alone is not a contraindication to surgical fixation of C2 fractures

Age alone is not a contraindication to surgical fixation of C2 fractures

Illinois Back Institute offers non-surgical treatment for lower back pain

Illinois Back Institute offers non-surgical treatment for lower back pain

No significant differences in absorption between tablet and softgel capsule forms of folic acid

No significant differences in absorption between tablet and softgel capsule forms of folic acid

Zyga Technology raises $25 million in Series C financing

Zyga Technology raises $25 million in Series C financing

Some hand function restored in quadriplegic patient with spinal cord injury

Some hand function restored in quadriplegic patient with spinal cord injury

HyperBranch’s Adherus AutoSpray Dural Sealant receives CE Marking

HyperBranch’s Adherus AutoSpray Dural Sealant receives CE Marking

AxioMed’s Freedom Cervical Disc receives CE Mark approval

AxioMed’s Freedom Cervical Disc receives CE Mark approval

OIC introduces Pedicle Screw System

OIC introduces Pedicle Screw System

SANUWAVE first quarter revenues decrease 5% to $238,540

SANUWAVE first quarter revenues decrease 5% to $238,540

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

Phase II trial to examine effects of resveratrol on individuals with mild to moderate dementia

NBHA commends FDA for continuing investigation of bisphosphonate treatment for osteoporosis

NBHA commends FDA for continuing investigation of bisphosphonate treatment for osteoporosis

'Packing problem' could have a solution for cancer treatment

'Packing problem' could have a solution for cancer treatment

Northstar Healthcare reports $0.6M net loss for first quarter 2012

Northstar Healthcare reports $0.6M net loss for first quarter 2012

Women with spine fractures can benefit from alendronate therapy

Women with spine fractures can benefit from alendronate therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.